ERNEXA THERAPEUTICS INC (ERNA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.31-4.86%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ERNA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 124.8% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
ERNA — President transition
Dated 2026-06-26
Senior Vice President of Finance — Sandra Gurrola: Ms. Gurrola resigned from her position as Senior Vice President of Finance.
Why it matters: If healthcare sector growth speeds up, it could boost ERNEXA's performance. Slowing growth may hurt investor confidence.
Watch forHealthcare sector revenue growth speeds up to 9% or more.
Also watch forHealthcare sector revenue growth keeps slowing below current levels.
Why it matters: Lower cash burn shows better money management. This can help how investors feel.
Supportive ifOperating cash burn decreases to less than $1.5M in the next quarter.
Worry ifOperating cash burn remains above $2.5M in the next quarter.
Why it matters: High operating losses may harm the company's future. Investors want to see better results.
Supportive ifOperating losses decrease to less than negative $4.0M in the next quarter.
Worry ifOperating losses remain at or worsen beyond negative $5.0M in the next quarter.
Why it matters: Finishing the public offering will give needed money for operations. It shows progress in finances.
Supportive ifERNA has finished a public offering. They sold 19 million shares.
Worry ifNo announcement of completion by the next earnings date on August 12, 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$481 on $10,000 · ±4.8% | How much price usually moves either way. |
| Bad day | $1,198 loss on $10,000 · 12.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,302 loss on $10,000 · 93.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Changes in leadership can affect company plans and stability. This impacts employee morale and investor trust.
Watch forERNA announces a new appointment for the Senior Vice President of Finance.
Also watch forNo new appointment is made within three months following the departure.
Why it matters: Leadership changes can impact company plans and results. Stable leaders help build investor trust.
Supportive ifThe company announces a new Senior Vice President of Finance.
Worry ifMore leaders leaving or issues in leadership roles.
Why it matters: The company received a notice about its share price being below $1.00. This affects its Nasdaq listing.
Worry ifThe company says it has met the Nasdaq minimum bid price again.
Less concerning ifThe company gets a delisting notice or does not meet the deadline.
Why it matters: The company needs to meet Nasdaq's minimum bid price of $1.00 per share. This affects its listing status.
Worry ifThe stock price stays below $1.00 for more than 30 consecutive trading days.
Less concerning ifThe stock price rises above $1.00 and stays there for 10 consecutive trading days.
Why it matters: The company received a notice for not meeting the $1.00 minimum bid price. This affects its listing.
Worry ifA public announcement confirming that the stock price has returned to or above $1.00.
Less concerning ifAnother Nasdaq notice or delisting warning due to continued low stock price.
Why it matters: The company is raising capital through a public offering. This is crucial for its financial health.
Supportive ifA press release says the public offering of 19 million shares is complete.
Worry ifFailure to complete the offering or a significant delay in the process.
Why it matters: Continued losses could signal deeper issues in managing costs and cash burn.
Worry ifOperating losses were worse than negative $5.59M in Q2.
Less concerning ifOperating losses improve to less than negative $4.1M in Q3.
Why it matters: The Senior VP of Finance left. This could change the financial strategy and operations.
Worry ifA new appointment helps stabilize the finance team and manage finances better.
Less concerning ifThere could be more instability or bad news after the executive change.